Skip to main content
Sino Biological Inc. logo

Sino Biological Inc. — Investor Relations & Filings

Ticker · 301047 ISIN · CNE100004Q23 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 485 across all filing types
Latest filing 2025-04-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301047

About Sino Biological Inc.

https://www.sinobiological.com

Sino Biological Inc. is a global provider of biological reagents and contract research services, specializing in recombinant protein and antibody technologies. The company maintains an extensive catalog of off-the-shelf products, including thousands of recombinant proteins, cytokines, viral antigens, and monoclonal antibodies. These resources support diverse applications in drug discovery, diagnostic development, and basic life science research. Beyond its product portfolio, the company offers comprehensive CRO services such as custom protein expression, antibody development, and biological testing. Utilizing high-throughput mammalian and insect cell expression platforms, Sino Biological provides scalable solutions for the pharmaceutical and biotechnology sectors. The organization is particularly noted for its rapid reagent development in response to emerging infectious diseases and its integrated approach to supporting the global research community.

Recent filings

Filing Released Lang Actions
2025年度财务预算报告
Regulatory Filings Classification · 90% confidence The document is titled '2025年度财务预算报告' which translates to '2025 Annual Financial Budget Report'. It is an internal management control indicator and a forecast for the company's 2025 operating plan. The text explicitly states it is a budget report based on the audited 2024 financial report but does not represent an official financial report or actual financial results. The document is short (821 characters) and appears to be a forward-looking budget plan rather than a formal financial report or announcement. It does not contain actual financial statements or results, nor is it an announcement of a report publication. Given these characteristics, it does not fit into categories like Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is also not a regulatory filing or certification. The best fitting category is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not neatly fit into other categories, especially since it is a budget report and not a formal financial report or announcement.
2025-04-18 Chinese
2024年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled as the "2024年度董事会工作报告" which translates to "2024 Annual Board of Directors Work Report." It details the board's activities, meetings, resolutions, and execution of shareholder meeting decisions during the 2024 fiscal year. It includes summaries of financial performance but does not contain full financial statements or detailed financial data. The document focuses on the board's work, governance, and oversight activities rather than being a full annual report or financial report. It is a report on board/management information, specifically the board's work report for the year. The document length is 3191 characters, which is relatively short and consistent with a board work report rather than a full annual report. Therefore, the most appropriate classification is Board/Management Information (MANG).
2025-04-18 Chinese
关于2024年度计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's asset impairment provision for the fiscal year 2024. It details the amount of impairment, the accounting standards applied, the impact on net profit and equity, and the approval process. The document is relatively short (1703 characters) and serves as a formal disclosure of an accounting adjustment rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Annual Report (10-K) or Interim Report (IR). It also does not fit categories like Earnings Release or Management Reports. Given the nature of the content and length, this is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2025-04-18 Chinese
2024年年度报告
Annual Report Classification · 100% confidence The document is titled as the '2024 Annual Report' of Beijing Sino Biological Technology Co., Ltd. It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, corporate governance, environmental and social responsibility, and financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes audited financial data, management analysis, and comprehensive disclosures. There is no indication that this is merely an announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-04-18 Chinese
董事会审计委员会对会计师事务所2024年度履职情况评估及履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee evaluating the performance and supervision of the accounting firm for the fiscal year 2024. It discusses the audit firm's qualifications, the audit process, and the audit results for the 2024 annual financial statements, including the issuance of an unqualified audit opinion and internal control audit report. The document is not the audit report itself but a supervisory report by the audit committee on the audit firm's work and their oversight activities. It is a standalone audit-related report focusing on audit evaluation and supervision, not a full annual report or financial statement. Therefore, it fits the category of Audit Report / Information (AR). The document length is 2186 characters, which is relatively short but contains substantive audit evaluation content, not just an announcement or certification. Hence, it is not RPA or RNS. Confidence is high due to clear audit committee evaluation content and references to audit standards and reports. FY 2024
2025-04-18 Chinese
2024年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) for the fiscal year 2024 of Beijing Yiqiao Shenzhou Technology Co., Ltd. It contains detailed audit opinions, basis for audit opinions, key audit matters, and extensive financial statement notes. The content includes auditor's responsibilities, management responsibilities, accounting policies, and detailed financial disclosures. The document length is substantial (15,000 characters), indicating it is the full audit report rather than a brief announcement or certification. There is no indication that this is an annual report or interim report, but rather a standalone audit report. Therefore, the document fits the category of Audit Report / Information (AR). FY 2024
2025-04-18 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.